Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery

Journal of Drug Targeting

Volumn 22, Issue 1, 2014, Pages 67-75

  Ding, Buyun ^a   Chen, Ping ^b   Kong, Yan ^c   Zhai, Yingjie ^a   Pang, Xin ^a   Dou, Jinfeng ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF JINAN   (China)

Author keywords

Folate receptor; Lipid nanocapsule; Quercetin; Simplex lattice experiment

Indexed keywords

FOLIC ACID; LIPID; NANOCAPSULE; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL KILLING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; FOLIC ACID; HELA CELLS; HUMANS; LIPIDS; MALE; MCF-7 CELLS; MICE; NANOCAPSULES; PARTICLE SIZE; QUERCETIN; RATS; SOLUBILITY;

EID: 84890330068     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.839685     Document Type: Article

References (48)

1. Silva MM, Santos MR, Caroco G, et al. Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radic Res 2002;36:1219-27.
2. Matsuda H, Morikawa T, Ando S, et al. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorg Med Chem 2003;11:1995-2000.
3. Boesch-saadatmandi C, Wagner AE, Wolffram S, Rimbach G. Effect of quercetin on inflammatory gene expression in mice liver in vivo-role of redox factor 1, mirna-122 and mirna-125b. Pharmacol Res 2012;65:523-30.
4. Russo GL. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 2007;74:533-44.
5. Radhika M, Ghoshal N, Chatterjee A. Comparison of effectiveness in antitumor activity between flavonoids and polyphenols of the methanolic extract of roots of potentilla fulgens in breast cancer cells. J Complement Integr Med 2012;9:article 24.
6. Vidya priyadarsini R, Senthil murugan R, Maitreyi S, et al. The flavonoid quercetin induces cell cycle arrest and mitochondriamediated apoptosis in human cervical cancer (hela) cells through p53 induction and nf-kappab inhibition. Eur J Pharmacol 2010;649: 84-91.
7. Kuo PC, Liu HF, Chao JI. Survivin and p53 modulate quercetininduced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 2004;279:55875-85.
8. Nguyen TT, Tran E, Nguyen TH, et al. The role of activated mekerk pathway in quercetin-induced growth inhibition and apoptosis in a549 lung cancer cells. Carcinogenesis 2004;25:647-59.
9. Talirevic E, Jelena S. Quercetin in the treatment of dyslipidemia. Med Arh 2012;66:87-8.
10. Boots AW, Drent M, de boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr 2011; 30:506-12.
11. Fasolo D, Schwingel L, Holzschuh M, et al. Validation of an isocratic lc method for determination of quercetin and methylquercetin in topical nanoemulsions. J Pharm Biomed Anal 2007;44: 1174-7.
12. Kumari A, Yadav SK, Pakade YB, et al. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B Biointerfaces 2010;80:184-92.
13. Chen X, Yin OQ, Zuo Z, Chow MS. Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 2005;22: 892-901.
14. Justino GC, Santos MR, Canario S, et al. Plasma quercetin metabolites: structure-antioxidant activity relationships. Arch Biochem Biophys 2004;432:109-21.
15. Heurtault B, Saulnier P, Pech B, et al. A novel phase inversionbased process for the preparation of lipid nanocarriers. Pharmaceut Res 2002;19:875-80.
16. Ghosh S, Dungdung SR, Chowdhury ST, et al. Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radic Biol Med 2011;51:1893-902.
17. Ramadan A, Lagarce F, Tessier-marteau A, et al. Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. Int J Nanomed 2011;6:2941-51.
18. Garcion E, Lamprecht A, Heurtault B, et al. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 2006;5:1710-22.
19. Jiang Q, Shi P, Li C, et al. (Coixan polysaccharide)- graftpolyethylenimine folate for tumor-targeted gene delivery. Macromol Biosci 2011;11:435-44.
20. Yao H, Ng SS, Tucker WO, et al. The gene transfection efficiency of a folate-pei600-cyclodextrin nanopolymer. Biomaterials 2009; 30:5793-803.
21. Han X, Liu J, Liu M, et al. 9-nc-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro. Int J Pharm 2009;372:125-31.
22. Xiang G, Wu J, Lu Y, et al. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm 2008; 356:29-36.
23. Xiong S, Yu B, Wu J, et al. Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-peg-chems. Biomed Pharmacother 2011;65:2-8.
24. Ferrari F, Bertoni M, Bonferoni CM, et al. Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design. Pharm Dev Technol 1996;1:159-64.
25. Gao Y, Wang Y, Ma Y, et al. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf B Biointerfaces 2009;71:306-14.
26. Feng C, Wang T, Tang R, et al. Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-peg-chems cells. Pediatr Surg Int 2011;26: 1185-91.
27. Li H, Lu Y, Piao L, et al. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid. Int J Pharm 2010;402:57-63.
28. Manojlovic V, Winkler K, Bunjes V, et al. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a rip ii protein. Colloids Surf B Biointerfaces 2008;64:284-96.
29. Singh B, Mehta G, Kumar R, et al. Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv 2005;2:143-53.
30. Sorensen EN, Weisman G, Vidaver GA. A sephadex column procedure for measuring uptake and loss of low molecular weight solutes from small, lipid-rich vesicles. Anal Biochem 1977;82: 376-84.
31. Zhao L, Shi Y, Zou S, et al. Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic p123 and d-a-tocopheryl polyethylene glycol succinate. J Biomed Nanotechnol 2011;7:358-65.
32. Li H, Zhao X, Ma Y, et al. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Rel 2009;133:238-44.
33. Duo J, Ying GG, Wang GW, Zhang L. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid. Mol Med Report 2010;5:1453-6.
34. Van der woude H, Gliszczynska-swiglo A, Struijs K, et al. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett 2003;200:41-7.
35. Huang LQ, Zhang W, Yang Y, Tao L. Effects and its mechanism of quercetin on cervical cancer hela cells. Zhonghua Fu Chan Ke Za Zhi 2009;44:436-9.
36. Hu K, Li J, Shen Y, et al. Lactoferrin-conjugated peg-pla nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Contr Rel 2009;134:55-61.
37. Allard E, Passirani C, Garcion E, et al. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J Contr Rel 2008;130: 146-53.
38. Tian QE, Li HD, Yan M, et al. Astragalus polysaccharides can regulate cytokine and p-glycoprotein expression in h22 tumorbearing mice. World J Gastroenterol 2012;18:7079-86.
39. Yuan ZP, Chen IJ, Fan L, et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 2006;12:3193-9.
40. Huynh NT, Passirani C, Saulnier P, Benoit JP. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009;379:201-9.
41. Ghosh D, Ghosh S, Sarkar S, et al. Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chem Biol Interact 2010;186:61-71.
42. Zhang L, Zhu W, Yang C, et al. A novel folate-modified selfmicroemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomed 2012;7:151-62.
43. Zhu W, Yu A, Wang W, et al. Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 2008;360:184-90.
44. Lamprecht A, Saumet JL, Roux J, Benoit JP. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 2004;278:407-14.
45. Abdel-mottaleb MM, Neumann D, Lamprecht A. In vitro drug release mechanism from lipid nanocapsules (lnc). Int J Pharm 2010; 390:208-13.
46. Khaled KA, El-sayed YM, Al-hadiya BM. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 2003;29:397-403.
47. Xu Y, Jin X, Ping Q, et al. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. J Control Rel 2010;146:299-308.
48. Wang R, Hu X, Wu S, et al. Biological characterization of folatedecorated biodegradable polymer-platinum(ii) complex micelles. Mol Pharm 2012;9:3200-8.